Impact

Burden of disease

Burden of disease analysis assesses the health impact on a population of different diseases, conditions, injuries and risk factors. The Australian Burden of Disease Study 2015 (AIHW 2019a) used information from a range of sources to quantify the fatal and non-fatal effects of these diseases.

Type 2 diabetes was the 12th largest contributor to Australia’s disease burden in 2015, accounting for 2.2% of total burden of disease. The burden from Type 2 diabetes increased slightly in 2011 (from 1.8% in 2003) and remained unchanged between 2011 and 2015 (2.2%).  Type 1 diabetes contributed to 0.3% of Australia’s disease burden in 2015—unchanged compared to both 2003 and 2011.

In 2015, 4.7% of the total burden of disease could have been prevented by reducing exposure to the modifiable risk factor high blood plasma glucose levels.

Expenditure

In 2015–16, an estimated 2.3% ($2.7 billion) of total disease expenditure in the Australian health system was attributed to Diabetes (AIHW 2019b). Further information is available from the Disease expenditure in Australia report.

References:

AIHW (Australian Institute of Health and Welfare) 2019a. Australian Burden of Disease Study: impact and causes of illness and death in Australia 2015. Australian Burden of Disease series no. 19. Cat. no. BOD 22. Canberra: AIHW. Viewed 25 June 2019, https://www.aihw.gov.au/reports/burden-of-disease/burden-disease-study-illness-death-2015/contents/table-of-contents.

AIHW 2019b. Disease expenditure in Australia. HWE 76. Canberra: AIHW. Viewed 13 June 2019, https://www.aihw.gov.au/reports/health-welfare-expenditure/disease-expenditure-australia/contents/summary.